IsoRay ships cesium-131 to Canada for research

01/26/2010 | (free registration)

IsoRay Medical is working with a Canadian customer on a study that aims to determine whether cesium-131 can be used to treat other malignant diseases aside from low-risk prostate cancer. The Richland, Wash.-based medical isotope developer said it has delivered a set of cesium-131 brachytherapy seeds to Canada for this purpose.

View Full Article in: (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC